The comparative analysis of the economic availability of antihypertensives from the group of beta-blockers in Ukraine

Authors

DOI:

https://doi.org/10.24959/sphhcj.24.315

Keywords:

cardiovascular diseases; arterial hypertension; beta-adrenergic blocking agents; pharmaceutical supply; socio-economic availability

Abstract

Aim. To conduct comparative studies of the economic availability of beta-adrenergic blocking agents at the domestic pharmaceutical market.

Materials and methods. Systematic, comparative, graphic, statistical and marketing research methods were used. The analysis of economic availability of medicines of beta-adrenergic receptor group (ATC code C07) registered in Ukraine in 2022-2024 was performed based on the results of calculation of the average retail price chain index (Ig), the indicator of solvency adequacy (Ca.s.) and the affordability index (D).

Results. The highest value of the average retail price chain index for January 2022/2023 and January 2023/2024 for medicines of C07 group of ATC was calculated for carvedilol, atenolol and combinations of atenolol with other diuretics. A slight decrease in the Ig index was recorded for nebivolol, bisoprolol, betaxolol and sotalol. The high Ca.s. index of bisoprolol, carvedilol, atenolol and metoprolol was due to the fact that there were 53 trade names in the Register of Medicines reimbursed under the terms of the “Affordable Medicines” government program. The calculated values of the D index for the drugs studied were greater than one. It is considered acceptable for consumers and determines high economic availability. However, the dynamics of a decrease in the overall affordability index in 2023-2024 compared to 2022-2023 indicates that the growth rate of drug prices exceeded the growth rate of wages.

Conclusions. The general trend towards a uniform increase in prices of β-blockers at the domestic pharmaceutical market has been studied. Taking into account the indicator of solvency adequacy and the affordability index, the analysis of the economic availability of the group of medicines studied makes it possible to determine the dynamics of a gradual improvement in the availability of medicines for the population, including due to the successful implementation of the government program for reimbursement of the cost of medicines by budget funds.

References

Pro zatverdzhennia Derzhavnoi stratehii realizatsii derzhavnoi polityky zabezpechennia naselennya likarskymy zasobamy na period do 2025 roku: postanova Kabinetu Ministriv Ukrainy vid 5.12.2018 r. No. 1022. Available at: https://zakon.rada.gov.ua/laws/show/1022-2018-п#Text

World Health Organization. 2021. Otsinka dostupnosti osnovnykh likarskykh zasobiv dlia ambulatornoho likuvannia v Ukrayini. Available at: https://www.who.int/ukraine/uk/publications/WHO-EURO-2021-2770-42528-59083

Symonenko, N. A., Podhayna, M. V., Nemchenko, A. S., Shpychak, O. S. (2021). Analiz ekonomichnoi dostupnosti okremykh hrup kardiolohichnykh preparativ v Ukraini za 2016–2020 roky. Farmatsevtychnyi chasopys, 2, 79-86. doi: 10.11603/2312-0967.2021.2.12183.

Boiev, S. S., Dotsenko, M. Y. A., Herasymenko. L. V., Shekhunova, I. O. (2020). Hipertonichna khvoroba certsya. Suchasnyi pohliad. Arterialna hipertenziia, 13, 2–3, 5-10. doi: 10.22141/2224-1485.13.2-3.2020.205333.

Mishchenko, O. Ya., Hreshko, Yu. I., Adonkina, V. Yu., Surikov, O. O. (2023). Analiz asortymentu, ekonomichnoi dostupnosti ta obsiahiv spozhyvannia antyestrohennykh zasobiv dlia hormonoterapii er(+) her2(−) raku molochnoi zalozy. Sotsialna farmatsiia v okhoroni zdorovia, 9, 4, 62-69. doi: 10.24959/sphhcj.23.306.

Tolochko, V. M., Mishchenko, O. Ya., Adonkina, V. Yu. (2015). Beta-adrenoblokatory: doslidzhennia asortymentu, sotsialno-ekonomichnoi dostupnosti ta obsiahiv spozhyvannia v Ukraini. ScienceRise, 12, 4 (17), 20-26.

Tkachova, O. V., Bohatyrchuk, L. P. (2016). Statyny: doslidzhennia asortymentu ta sotsialno-ekonomichnoi dostupnosti dlia ukrainskykh patsiientiv. Suchasni napriamky udoskonalennia farmatsevtychnoho zabezpechennia naselennia na rehionalnomu rivni : materialy nauk.-prakt. rehionalnoi konf., m. Ivano-Frankivsk, 10-11 trav. 2016 r. Ivano-Frankivsk : PP Holiney O. M.

Williams, B., Mancia, G., Spiering, W., Rosei, E. A., Azizi, M., Burnier, M. et al. (2018). 2018 ESC/ESH Guidelines for the management of arterial hypertension. European heart journal, 39, 33, 3021-3104. doi: 10.1093/eurheartj/ehy 339.

Poliakova, D. S. Obyraiemo blokator b-adrenoretseptoriv vidpovidno do potreb patsiienta. Ukrayinskyi medychnyi chasopys. Available at: https://umj.com.ua/uk/publikatsia-241111-obirayemo-blokator-adrenoretseptoriv-vidpovidno-do-potreb-patsiyenta.

Pro zatverdzhennia Perelikiv likarskykh zasobiv i medychnykh vyrobiv, yaki pidliahaiut reimbursatsii za prohramoiu derzhavnykh harantii medychnoho obsluhovuvannia naselennia, stanom na 10 serpnia 2023 roku : nakaz Ministerstva okhorony zdorovia Ukrayiny vid 21.08.2023 No. 1495. Available at: https://zakon.rada.gov.ua/rada/show/v1495282-23#Text.

Pokotylo, O. O., Aleshchenko. O. Yu. (2023). Analiz realizatsii derzhavnoi prohramy reimbursatsii yak skladovoho protsesu zabezpechennia dostupnosti farmatsevtychnoi dopomohy naselenniu. Farmatsevtychny chasopys, 2, 61-70. doi: 10.11603/2312-0967.2023.2.13870.

Malanchuk, N. V., Demchuk, M. B., Hroshovyi, T. A. (2022). Doslidzhennia asortymentu antyhipertenzyvnykh likarskykh zasobiv ta analiz yikh ekonomichnoi dostupnosti za umov realizatsii uryadovoi prohramy “Dostupni liky”. Farmatsevtychnyi chasopys, 4, 5-13. doi: 10.11603/2312-0967.2022.3.13540.

Apteka. Broniuvannia likiv. Available at: https://buy.apteka.ua/uk.

Ministerstvo finansiv Ukrainy. Available at: https://minfin.com.ua/ua/2024/01/01/118892767/.

Derzhavna sluzhba statystyky Ukrainy. Available at: https://www.ukrstat.gov.ua.

Khodakivska, V. P., Senkiv, N. M. (2022). Otsinka ekonomichnoi dostupnosti likarskykh zasobiv protyvirusnoi dii roslynnoho pokhodzhennia, predstavlenykh na vitchyznianomu farmatsevtychnomu rynku. Visnyk farmatsii, 1 (103), 108-114. doi: 10.24959/nphj.22.64.

Downloads

Published

2024-05-02

Issue

Vol. 10 No. 1 (2024)

Section

Organizational and socio-economic bases of pharmaceutical activities

License

Copyright (c) 2024 National University of Pharmacy

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).